BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 20952512)

  • 1. RAD51C: a novel cancer susceptibility gene is linked to Fanconi anemia and breast cancer.
    Somyajit K; Subramanya S; Nagaraju G
    Carcinogenesis; 2010 Dec; 31(12):2031-8. PubMed ID: 20952512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct roles of FANCO/RAD51C protein in DNA damage signaling and repair: implications for Fanconi anemia and breast cancer susceptibility.
    Somyajit K; Subramanya S; Nagaraju G
    J Biol Chem; 2012 Jan; 287(5):3366-80. PubMed ID: 22167183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi anemia and breast cancer susceptibility meet again.
    Levy-Lahad E
    Nat Genet; 2010 May; 42(5):368-9. PubMed ID: 20428093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.
    Meindl A; Hellebrand H; Wiek C; Erven V; Wappenschmidt B; Niederacher D; Freund M; Lichtner P; Hartmann L; Schaal H; Ramser J; Honisch E; Kubisch C; Wichmann HE; Kast K; Deissler H; Engel C; Müller-Myhsok B; Neveling K; Kiechle M; Mathew CG; Schindler D; Schmutzler RK; Hanenberg H
    Nat Genet; 2010 May; 42(5):410-4. PubMed ID: 20400964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of the RAD51C gene in a Fanconi anemia-like disorder.
    Vaz F; Hanenberg H; Schuster B; Barker K; Wiek C; Erven V; Neveling K; Endt D; Kesterton I; Autore F; Fraternali F; Freund M; Hartmann L; Grimwade D; Roberts RG; Schaal H; Mohammed S; Rahman N; Schindler D; Mathew CG
    Nat Genet; 2010 May; 42(5):406-9. PubMed ID: 20400963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious RAD51C germline mutations rarely predispose to breast and ovarian cancer in Pakistan.
    Rashid MU; Muhammad N; Faisal S; Amin A; Hamann U
    Breast Cancer Res Treat; 2014 Jun; 145(3):775-84. PubMed ID: 24800917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Germline RAD51C mutations in ovarian cancer susceptibility.
    Coulet F; Fajac A; Colas C; Eyries M; Dion-Minière A; Rouzier R; Uzan S; Lefranc JP; Carbonnel M; Cornelis F; Cortez A; Soubrier F
    Clin Genet; 2013 Apr; 83(4):332-6. PubMed ID: 22725699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further evidence for the contribution of the RAD51C gene in hereditary breast and ovarian cancer susceptibility.
    Vuorela M; Pylkäs K; Hartikainen JM; Sundfeldt K; Lindblom A; von Wachenfeldt Wäppling A; Haanpää M; Puistola U; Rosengren A; Anttila M; Kosma VM; Mannermaa A; Winqvist R
    Breast Cancer Res Treat; 2011 Dec; 130(3):1003-10. PubMed ID: 21750962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast cancer and Fanconi anemia: what are the connections?
    Zdzienicka MZ; Arwert F
    Trends Mol Med; 2002 Oct; 8(10):458-60. PubMed ID: 12383764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline mutation in the RAD51B gene confers predisposition to breast cancer.
    Golmard L; Caux-Moncoutier V; Davy G; Al Ageeli E; Poirot B; Tirapo C; Michaux D; Barbaroux C; d'Enghien CD; Nicolas A; Castéra L; Sastre-Garau X; Stern MH; Houdayer C; Stoppa-Lyonnet D
    BMC Cancer; 2013 Oct; 13():484. PubMed ID: 24139550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of germline RAD51C missense variants highlight the role of RAD51C in replication fork protection.
    Kolinjivadi AM; Chong ST; Choudhary R; Sankar H; Chew EL; Yeo C; Chan SH; Ngeow J
    Hum Mol Genet; 2023 Apr; 32(8):1401-1409. PubMed ID: 36562461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.
    Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A
    Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen induces RAD51C expression and localization to sites of DNA damage.
    Alayev A; Salamon RS; Manna S; Schwartz NS; Berman AY; Holz MK
    Cell Cycle; 2016 Dec; 15(23):3230-3239. PubMed ID: 27753535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Homologous recombination-deficient mutation cluster in tumor suppressor
    Prakash R; Rawal Y; Sullivan MR; Grundy MK; Bret H; Mihalevic MJ; Rein HL; Baird JM; Darrah K; Zhang F; Wang R; Traina TA; Radke MR; Kaufmann SH; Swisher EM; Guérois R; Modesti M; Sung P; Jasin M; Bernstein KA
    Proc Natl Acad Sci U S A; 2022 Sep; 119(38):e2202727119. PubMed ID: 36099300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian RAD51 paralogs protect nascent DNA at stalled forks and mediate replication restart.
    Somyajit K; Saxena S; Babu S; Mishra A; Nagaraju G
    Nucleic Acids Res; 2015 Nov; 43(20):9835-55. PubMed ID: 26354865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RAD51 paralogs: Expanding roles in replication stress responses and repair.
    Bhattacharya D; Sahoo S; Nagraj T; Dixit S; Dwivedi HK; Nagaraju G
    Curr Opin Pharmacol; 2022 Dec; 67():102313. PubMed ID: 36343481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening RAD51C nucleotide alterations in patients with a family history of breast and ovarian cancer.
    Zheng Y; Zhang J; Hope K; Niu Q; Huo D; Olopade OI
    Breast Cancer Res Treat; 2010 Dec; 124(3):857-61. PubMed ID: 20697805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families.
    Johnson J; Healey S; Khanna KK; ; Chenevix-Trench G
    Breast Cancer Res Treat; 2011 Aug; 129(1):255-63. PubMed ID: 21533530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interplay between human DNA repair proteins at a unique double-strand break in vivo.
    Rodrigue A; Lafrance M; Gauthier MC; McDonald D; Hendzel M; West SC; Jasin M; Masson JY
    EMBO J; 2006 Jan; 25(1):222-31. PubMed ID: 16395335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RAD51C facilitates checkpoint signaling by promoting CHK2 phosphorylation.
    Badie S; Liao C; Thanasoula M; Barber P; Hill MA; Tarsounas M
    J Cell Biol; 2009 May; 185(4):587-600. PubMed ID: 19451272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.